Anthony Marucci
Vermögen: 1 Mio $ am 31.05.2026
Vermögen: 1 Mio $ am 31.05.2026
Mr. Anthony S.
Marucci is a President, CEO, CFO, Secretary, Treasurer & VP at Celldex Research Corp.
and a President, Chief Executive Officer & Director at Celldex Therapeutics, Inc. He is on the Board of Directors at BioNJ, Inc., Celldex Therapeutics, Inc., Celldex Therapeutics Ltd. and College of Business & Public Management.
Mr. Marucci was previously employed as an Independent Director by Genenta Science SpA, an Interim President & Chief Executive Officer by AVANT Immunotherapeutics, Inc., a Treasurer & Acting Chief Executive Officer by Celldex Therapeutics, Inc. (Old), a Treasurer by Medarex, Inc., and a President by CuraGen Corp.
He received his undergraduate degree from Kean University, a graduate degree from Brown University and an MBA from The Trustees of Columbia University in The City of New York.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.06.2026 | 41’675 ( 0.05% ) | 1 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CELLDEX THERAPEUTICS, INC. | Gründer | 01.01.1983 |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Direktor/Vorstandsmitglied | 01.01.2010 |
Celldex Therapeutics Ltd. | Direktor/Vorstandsmitglied | 06.08.2010 |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Vorstandsvorsitzender | 01.05.2003 |
College of Business & Public Management | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Präsident | 01.10.2008 |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Treasurer | 01.03.2004 |
| GENENTA SCIENCE S.P.A. | Direktor/Vorstandsmitglied | - |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Präsident | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 13 |
|---|---|
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. Medical SpecialtiesHealth Technology Discovers, develops and commercializes vaccines and therapeutics | Health Technology |
Celldex Therapeutics, Inc. (Old)
Celldex Therapeutics, Inc. (Old) BiotechnologyHealth Technology Discovers, develops and commercializes novel immunotherapeutics | Health Technology |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kean University
Kean University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes immunotherapy technologies for the treatment of cancer and other diseases | Health Technology |
Celldex Research Corp.
Celldex Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in provision of biological research and development | Commercial Services |
Celldex Therapeutics Ltd. | |
Genenta Science SpA
Genenta Science SpA Pharmaceuticals: MajorHealth Technology Develops gene transfer therapy for the treatment of cancer tumors | Health Technology |
College of Business & Public Management |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen